143 related articles for article (PubMed ID: 2266393)
1. Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging.
Burman KD; Anderson JH; Wartofsky L; Mong DP; Jelinek JJ
J Nucl Med; 1990 Dec; 31(12):1958-64. PubMed ID: 2266393
[TBL] [Abstract][Full Text] [Related]
2. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
Hsu CC; Chen YW; Huang YF; Chuang YW
Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
4. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
5. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
6. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
7. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
9. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
[TBL] [Abstract][Full Text] [Related]
10. Thallium-201 SPECT increases detectability of thyroid cancer metastases.
Charkes ND; Vitti RA; Brooks K
J Nucl Med; 1990 Feb; 31(2):147-53. PubMed ID: 2313353
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphy with 201Tl for detection of thyroid cancer metastases.
Piers DA; Sluiter WJ; Willemse PH; Doorenbos H
Eur J Nucl Med; 1982; 7(11):515-7. PubMed ID: 7173250
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow changes in patients with thyroid carcinoma].
Linden A; Weiss R; Smolarz K; Jungehülsing M; Theissen P; Schicha H
Nuklearmedizin; 1991 Dec; 30(6):272-8. PubMed ID: 1780240
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
14. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical changes in iodine-131 scintigraphic findings in advanced follicular thyroid cancer.
Krishna L; Dadparvar S; Brady LW; Micaily B; Meihofer M; Slizofski WJ; Brown SJ; Chevres A; Roman R; Khan AS
J Nucl Med; 1993 Sep; 34(9):1574-6. PubMed ID: 8355078
[TBL] [Abstract][Full Text] [Related]
16. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
Tonami N; Hisada K
Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
18. Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy.
Ohnishi T; Noguchi S; Murakami N; Jinnouchi S; Hoshi H; Futami S; Watanabe K
AJNR Am J Neuroradiol; 1993; 14(5):1051-7. PubMed ID: 8237680
[TBL] [Abstract][Full Text] [Related]
19. The rational use of 201Tl scintigraphy in the evaluation of differentiated thyroid cancer.
Nĕmec J; Zamrazil V; Pohunková D; Röhling S; Holub V
Eur J Nucl Med; 1984; 9(6):261-4. PubMed ID: 6745296
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Tl-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumor: concise communication.
Senga O; Miyakawa M; Shirota H; Makiuchi M; Yano K; Miyazawa M; Takizawa M
J Nucl Med; 1982 Mar; 23(3):225-8. PubMed ID: 6950032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]